Basic Information
| LncRNA/CircRNA Name | HMLINCRNA717 |
| Synonyms | HMlincRNA717, GACAT2, MTCL1-AS1, MTCL1AS1 |
| Region | GRCh38_18:8695856-8707621 |
| Ensemble | ENSG00000265962 |
| Refseq | NR_120598 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR etc. |
| Sample | NSCLC tissues, cell lines (A549, H157, HEK-293T) |
| Expression Pattern | down-regulated |
| Function Description | lncRNA HMlincRNA717 expression level was significantly decreased in NSCLC tissues in comparison to adjacent non-tumor tissues. It was also proved that HMlincRNA717 expression was to be associated with NSCLC histological grade, and lymph node metastasis. In addition, survival analysis proved that down-regulated HMlincRNA717 expression was associated with poor overall survival of NSCLC patients. HMlincRNA717 expression was an independent prognostic factor for patients with NSCLC, which might be a potential prognostic biomarker and therapeutic target for NSCLC. |
| Pubmed ID | 25674259 |
| Year | 2015 |
| Title | LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. |
External Links
| Links for HMLINCRNA717 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |